终末期肾脏病患者肌少症的研究进展

doi:10.3761/j.issn.0254-1769.2019.09.029

摘要/Abstract

摘要：

肌少症是终末期肾脏病患者的并发症之一,与多种疾病不良结局密切相关。该文对终末期肾脏病患者肌少症的筛查方法、影响因素及干预措施进行综述,旨在为预防和干预终末期肾脏病患者肌少症提供借鉴。

关键词: 肾功能不全, 终末期肾脏病, 肌少症, 综述

Abstract:

Key words: Renal Insufficiency, End-Stage Renal Disease, Sarcopenia, Review

高雅靖, 单岩, 杜理平, 李艳艳, 蒋婷婷, 蒋鑫鑫, 蔡利, 周越. 终末期肾脏病患者肌少症的研究进展[J]. 中华护理杂志, 2019, 54(9): 1423-1426.

参考文献 39

[1]	严淑, 陆亚华, 汪良芝 . 老年肌少症的诊治和研究新进展[J]. 中国老年学杂志, 2018,38(22):5610-5613.
[2]	任红旗, 龚德华 . 尿毒症肌少症的发病机制和治疗[J]. 肾脏病与透析肾移植杂志, 2015,24(2):181-185.
[3]	Molfino A, Chiappini MG, Laviano A , et al. Effect of intensive nutritional counseling and support on clinical outcomes of hemodialysis patients[J]. Nutrition, 2012,28(10):1012-1015.
[4]	Chen LK, Liu LK, Woo J , et al. Sarcopenia in Asia:consensus report of the Asian working group for sarcopenia[J]. J Am Med Dir Assoc, 2014,15(2):95-101.
[5]	Lamarca F, Carrero JJ, Rodrigues JC , et al. Prevalence of sarcopenia in elderly maintenance hemodialysis patients:the impact of different diagnostic criteria[J]. J Nutr Health Aging, 2014,18(7):710-717.
[6]	Heymsfield SB, Adamek M, Gonzalez MC , et al. Assessing ske-letal muscle mass:historical overview and state of the art[J]. J Cachexia Sarcopenia Muscle, 2014,5(1):9-18.
[7]	Sharma D, Hawkins M, Abramowitz MK . Association of sarcopenia with eGFR and misclassification of obesity in adults with CKD in the United States[J]. Clin J Am SocNephrol, 2014,9(12):2079-2088.
[8]	van Baar H, Hulshof PJM, Tieland M , et al. Bio-impedance ana-lysis for appendicular skeletal muscle mass assessment in (pre-)frail elderly people[J]. Clin Nutr ESPEN, 2015,10(4):e147-e153.
[9]	Lai S, Muscaritoli M, Andreozzi P , et al. Sarcopenia and cardiovascular risk indices in patients with chronic kidney disease on conservative and replacement therapy[J]. Nutrition, 2019,62:108-114.
[10]	Kutner NG, Zhang R, Huang YJ , et al. Gait speed and mortality,hospitalization,and functional status change among hemodialysis patients:a US renal data system special study[J]. Am J Kidney Dis, 2015,66(2):297-304.
[11]	叶丽钦, 张海林, 周莹 . 血液透析患者衰弱的相关研究进展[J]. 中华护理杂志, 2018,53(1):99-104.
[12]	Fried LP, Tangen CM, Walston J , et al. Frailty in older adults:evidence for a phenotype[J]. J Gerontol A Biol Med Sci, 2001,56(3):M146-M156.
[13]	王思远, 高敏, 赵岳 . 中文版慢性病治疗功能评估-疲劳量表在维持性血液透析患者中的信效度评定[J]. 中华护理杂志, 2014,49(5):613-617.
[14]	Noori N, Kopple JD, Kovesdy CP , et al. Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients[J]. Clin J Am Soc Nephrol, 2010,5(12):2258-2268.
[15]	Kovesdy CP, Kopple JD, Kalantar-Zadeh K . Management of pro-tein-energy wasting in non-dialysis-dependent chronic kidney disease:reconciling low protein intake with nutritional therapy[J]. Am J Clin Nutr, 2013,97(6):1163-1177.
[16]	Fahal IH . Uraemic sarcopenia:aetiology and implications[J]. Nephrol Dial Transplant, 2014,29(9):1655-1665.
[17]	卢湘, 白姣姣, 王峥 . 终末期肾病患者营养评估工具的研究进展[J]. 护理学杂志, 2014,29(1):88-90.
[18]	Souza VA, Oliveira D, Barbosa SR , et al. Sarcopenia in patients with chronic kidney disease not yet on dialysis:analysis of the prevalence and associated factors[J]. PLoS One, 2017,12(4):e0176230.
[19]	董志娟, 张海林 . 维持性血液透析患者肌少症发生的危险因素分析[J]. 护理学杂志, 2018,33(9):20-24.
[20]	Trierweiler H, Kisielewicz G, Hoffmann Jonasson T , et al. Sarcopenia:a chronic complication of type 2 diabetes mellitus[J]. Diabetol Metab Syndr, 2018,10:25.
[21]	Mori K, Nishide K, Okuno S , et al. Impact of diabetes on sarcopenia and mortality in patients undergoing hemodialysis[J]. BMC Nephrol, 2019,20(1):105.
[22]	Edwards MH, Dennison EM, Aihie Sayer A , et al. Osteoporosis and sarcopenia in older age[J]. Bone, 2015,80:126-130.
[23]	罗群, 王来亮 . 慢性肾脏病维生素D缺乏与肌少症[J]. 现代实用医学, 2017,29(12):1549-1550,1554.
[24]	Hsu YH, Liang CK, Chou MY , et al. Association of cognitive impairment,depressive symptoms and sarcopenia among healthy older men in the veterans retirement community in southern Taiwan:a cross-sectional study[J]. Geriatr Gerontol Int, 2014,14(Suppl 1):102-108.
[25]	Alston H, Burns A, Davenport A . Loss of appendicular muscle mass in haemodialysis patients is associated with increased self-reported depression,anxiety and lower general health scores[J]. Nephrology(Carlton), 2018,23(6):546-551.
[26]	Abiri B, Vafa M . Nutrition and sarcopenia:a review of the evidence of nutritional influences[J]. Crit Rev Food Sci Nutr, 2019,59(9):1456-1466.
[27]	臧华龙, 秦学祥, 翁敏 . 口服营养补充剂对维持性血液透析病人肌少症及生存质量的影响[J]. 肠外与肠内营养, 2018,25(6):349-354.
[28]	Vongsanim S, Davenport A . Estimating dietary protein intake in peritoneal dialysis patients:the effect of ethnicity[J]. Perit Dial Int, 2018,38(5):384-387.
[29]	董志娟 . 抗阻力运动对维持性血液透析患者肌少症干预效果的研究[D]. 南京:南京医科大学, 2018.
[30]	Isoyama N, Qureshi AR, Avesani CM , et al. Comparative associations of muscle mass and muscle strength with mortality in dialysis patients[J]. Clin J Am Soc Nephrol, 2014,9(10):1720-1728.
[31]	Johansen KL, Mulligan K, Schambelan M . Anabolic effects of nandrolone decanoate in patients receiving dialysis:a randomized controlled trial[J]. JAMA, 1999,281(14):1275-1281.
[32]	Lee MJ, Lee SA, Nam BY , et al. Irisin,a novel myokine is an independent predictor for sarcopenia and carotid atherosclerosis in dialysis patients[J]. Atherosclerosis, 2015,242(2):476-482.
[33]	Mori A, Nishino T, Obata Y , et al. The effect of active vitamin D administration on muscle mass in hemodialysis patients[J]. Clin Drug Investig, 2013,33(11):837-846.
[34]	Yamada S, Tsuruya K, Yoshida H , et al. Factors associated with the serum myostatin level in patients undergoing peritoneal dialysis:potential effects of skeletal muscle mass and vitamin D receptor activator use[J]. Calcif Tissue Int, 2016,99(1):13-22.
[35]	de Brito-Ashurst I, Varagunam M, Raftery MJ , et al. Bicarbonate supplementation slows progression of CKD and improves nutritional status[J]. J Am Soc Nephrol, 2009,20(9):2075-2084.
[36]	Verove C, Maisonneuve N, El Azouzi A , et al. Effect of the correction of metabolic acidosis on nutritional status in elderly patients with chronic renal failure[J]. J Ren Nutr, 2002,12(4):224-228.
[37]	叶丽钦, 周莹, 张海林 , 等. 维持性血液透析患者衰弱及其表型对生活质量的影响研究[J]. 中华护理杂志, 2018,53(9):1072-1077.
[38]	Picariello F, Hudson JL, Moss-Morris R , et al. Examining the efficacy of social-psychological interventions for the management of fatigue in end-stage kidney disease(ESKD):a syste-matic review with meta-analysis[J]. Health Psychol Rev, 2017,11(2):197-216.
[39]	Kauric Klein Z . Effect of yoga on physical and psychological outcomes in patients on chronic hemodialysis[J]. Complement Ther Clin Pract, 2019,34:41-45.

终末期肾脏病患者肌少症的研究进展

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 39

相关文章 15

编辑推荐

Metrics

[1]	刘梦媛, 田凌云, 蒋敬, 冯心语, 李卫娟, 罗慧, 李映兰. 护士在跨专业合作中伦理冲突的范围综述[J]. 中华护理杂志, 2024, 59(9): 1138-1144.
[2]	崔怡爽, 何细飞, 王昭昭, 程捷, 杨伟梅, 陆丽娟. 共享决策在急性冠脉综合征患者中应用的范围综述[J]. 中华护理杂志, 2024, 59(9): 1145-1152.
[3]	张小艳, 李学靖, 杨丹, 孟美琪, 郝玉芳. 老年人久坐行为干预策略的范围综述[J]. 中华护理杂志, 2024, 59(8): 1012-1020.
[4]	余良梦, 俞小玲, 李佳镁, 阮晓芬. 证据图谱在护理学领域的应用进展[J]. 中华护理杂志, 2024, 59(8): 1021-1025.
[5]	房钰, 郝媛媛, 张晨, 董莹, 吴赢鑫, 姜桂春. 癌症患者决策疲劳的研究进展及护理启示[J]. 中华护理杂志, 2024, 59(8): 941-946.
[6]	叶磊, 夏广惠, 陈方梅, 田宇燕, 祁玮. 虚拟现实技术在癌症相关认知障碍患者中应用的范围综述[J]. 中华护理杂志, 2024, 59(7): 882-889.
[7]	熊桃, 谭雪梅, 罗静, 李阳, 郑予希, 李奉玲, 魏雪梅, 崔丽君, 罗澜峻. 脑卒中患者康复动机评估工具的研究进展[J]. 中华护理杂志, 2024, 59(7): 890-896.
[8]	颜钰, 龚姝, 段棣飞, 马登艳. 知识图谱在慢性病患者饮食管理中的应用进展[J]. 中华护理杂志, 2024, 59(6): 753-757.
[9]	邓艺帆, 王建宁, 彭梦婷, 洪杜. 决策辅助工具在失智症患者照护中应用的范围综述[J]. 中华护理杂志, 2024, 59(6): 758-763.
[10]	张淼淼, 张丽, 闫荣, 丁敏, 孟祥敏, 徐萍. 网络哀伤辅导在安宁疗护中的应用进展[J]. 中华护理杂志, 2024, 59(5): 556-561.
[11]	徐榕璟, 贺旭妍, 贾守梅. 骨科老年患者术后运动恐惧的范围综述[J]. 中华护理杂志, 2024, 59(5): 626-633.
[12]	王思琦, 范玲. 护士出勤主义行为的研究进展[J]. 中华护理杂志, 2024, 59(5): 634-640.
[13]	王晴, 黄晓婷, 唐四元, 黄重梅. 即时适配干预在护理领域中的应用进展[J]. 中华护理杂志, 2024, 59(4): 490-495.
[14]	周王青, 刘言, 刘力硕, 李佳, 朱蓝玉, 尹晓彤. 综合护理彩虹模型的研究进展及启示[J]. 中华护理杂志, 2024, 59(4): 496-501.
[15]	沈美頔, 高瑞桐, 许林琪, 黄奇芳, 付立, 程思铭, 王崇锟, 任利华. 理论评价工具在护理领域中的应用进展[J]. 中华护理杂志, 2024, 59(4): 502-505.